Comparative table of genito ulcerative disease microbiology related

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have comprehensive data. Let me compile the full comparative table from all these sources:

Here is a comprehensive comparative table of Genito-Ulcerative Diseases (GUD) covering microbiology and key clinical-diagnostic features:

Comparative Table: Genito-Ulcerative Diseases (GUD) - Microbiology

Feature	Syphilis	Genital Herpes	Chancroid	Lymphogranuloma Venereum (LGV)	Granuloma Inguinale (Donovanosis)
Causative Organism	Treponema pallidum	Herpes Simplex Virus type 1 & 2 (HSV-1/HSV-2)	Haemophilus ducreyi	Chlamydia trachomatis serovars L1, L2, L3	Klebsiella granulomatis (formerly Calymmatobacterium granulomatis)
Type of Organism	Spirochete (gram-variable)	dsDNA virus (Herpesviridae)	Gram-negative coccobacillus	Obligate intracellular bacterium	Gram-negative encapsulated intracellular coccobacillus
Ulcer Characteristics	Single, painless, indurated, clean base (chancre)	Multiple, small, shallow, grouped vesicles coalescing into ulcers	Multiple, painful, irregular, soft (non-indurated), purulent/ragged edges	Small, shallow, transient ulcer (often missed); later proctocolitis with fistulas/strictures	Painless, beefy-red, friable, bleeding, progressive "serpiginous" ulcer; no true adenopathy
Pain	No (painless)	Yes (painful, burning)	Yes (very painful)	No (painless; often unnoticed)	No (painless)
Induration	Hard (indurated)	None	Soft (non-indurated) - "soft chancre"	None / soft	None / soft, vascular
Inguinal Lymphadenopathy	Firm, rubbery, non-tender ("shotty") nodes	Bilateral tender adenopathy	~50% - painful, fluctuant (bubo), may suppurate	Tender, suppurative unilateral bubo; "groove sign" (Greenblatt sign)	Absent (pseudobuboes - subcutaneous granulomas, not true LN swelling)
Number of Ulcers	Usually single	Multiple	Multiple	Single (primary); often missed	Single or multiple, progressive
Incubation Period	9-90 days (avg. 21 days)	2-12 days	1-14 days	3-21 days	2 weeks - 6 months
Natural History	Self-limiting chancre; progresses to secondary, tertiary stages	Recurrent; establishes latency in dorsal root ganglia	Heals in weeks with treatment; suppurative bubo may require drainage	Progressive; fibrosis, strictures, fistulae if untreated	Slowly progressive; destructive; may cause genital elephantiasis
Lab Diagnosis	Dark-field microscopy, RPR/VDRL (non-treponemal), TPHA/FTA-Abs (treponemal), PCR	Tzanck smear (multinucleated giant cells), viral culture, PCR (gold standard), type-specific serology	Culture on special media (chocolate agar + vancomycin); PCR; Gram stain shows "school of fish" pattern	Complement fixation / ELISA (Chlamydia Ab); PCR on swab; culture (cell line)	Tissue biopsy / smear showing Donovan bodies (intracytoplasmic organisms in macrophages) on Giemsa or Wright stain
Microscopy Finding	Spirochetes on dark-field	Cowdry type A intranuclear inclusions; multinucleated giant cells	"School of fish" / "railroad tracks" on Gram stain	Intracytoplasmic inclusions in McCoy cells	Donovan bodies - encapsulated organisms in vacuolated macrophages (looks like "safety pins")
Gram Stain	Not applicable (gram-variable spirochete)	Not applicable (virus)	Gram-negative short rods in chains ("school of fish")	Not applicable (obligate intracellular)	Gram-negative coccobacilli within macrophages
Special Culture Requirements	Cannot be cultured in vitro	Standard viral culture (Vero cells)	Requires X factor (hemin), enriched media; fastidious	Requires cell culture (McCoy/HeLa cells)	Cannot be grown on standard media; requires cell-based culture (rarely done)
Serological Tests	RPR, VDRL, TPHA, FTA-Abs	Type-specific IgG (gG-based assay: gG-1/gG-2)	None routinely available	Microimmunofluorescence; ELISA	None reliable
Treatment (First Line)	Benzathine Penicillin G 2.4 MU IM (single dose for primary/secondary)	Acyclovir / Valacyclovir / Famciclovir	Azithromycin 1 g PO single dose OR Ceftriaxone 250 mg IM	Doxycycline 100 mg PO BID x 21 days	Doxycycline 100 mg BID x ≥3 weeks (until lesions heal)
Alternative Treatment	Doxycycline 100 mg BID x 14 days (penicillin allergy)	Topical for mild cases; IV acyclovir for severe/disseminated	Ciprofloxacin 500 mg BID x 3 days; Erythromycin 500 mg TID x 7 days	Azithromycin 1 g weekly x 3 weeks; Erythromycin 500 mg QID x 21 days	Azithromycin 1 g weekly; trimethoprim-sulfamethoxazole
HIV Co-factor Risk	Yes - increased HIV transmission	Yes - significant co-factor	Yes - major co-factor	Yes	Yes
Epidemiology	Worldwide; rising incidence (especially MSM)	Most common cause of GUD globally	Developing countries (Africa, Southeast Asia); rare in USA	Endemic tropics; MSM outbreaks in Western Europe	Endemic in India, Papua New Guinea, South Africa, Caribbean; rare in USA
Recurrence	No (unless reinfection)	Yes - frequent recurrence	No	No	No (but slowly progressive if untreated)
Vaccine Available	No	No	No	No	No
Notifiable Disease	Yes	No (in most countries)	Yes	Yes	Yes

Quick Memory Aid: Painful vs. Painless

PAINFUL ulcers	PAINLESS ulcers
Herpes simplex (HSV)	Syphilis (primary chancre)
Chancroid (H. ducreyi)	LGV (primary lesion)
	Donovanosis (K. granulomatis)

Key Distinguishing Mnemonics

Syphilis = "Hard chancre" - indurated, painless, heals spontaneously
Chancroid = "Soft chancre" - painful, purulent, non-indurated; H. ducreyi needs X factor (hemin) - "X-rated disease"
LGV = "Groove sign" - inguinal ligament divides the bubo into two masses above and below; caused by C. trachomatis L1, L2, L3
Donovanosis = "Donovan bodies" in macrophages - looks like "safety pin" organisms; beefy-red ulcer with no true lymphadenopathy
Herpes = Only viral cause; only one that recurs; Tzanck smear shows multinucleated giant cells

Sources: Tintinalli's Emergency Medicine (Table 153-3), Smith & Tanagho's General Urology 19e, Washington Manual of Medical Therapeutics, Goldman-Cecil Medicine, Harrison's Principles of Internal Medicine 22e (2025)

Detailed microbiology of herpesviridiae

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive detail from the Murray Medical Microbiology textbook. Let me compile the full, detailed response:

Detailed Microbiology of the Herpesviridae

Family Overview

The Herpesviridae are a family of large, enveloped, double-stranded DNA viruses. All members share a conserved 4-layer structure and the defining biological hallmark of latency.

Virion Structure (applies to ALL herpesviruses)

Layer	Component	Details
Core	Linear dsDNA genome	120-250 kb; contains unique long (UL) and unique short (US) regions bracketed by direct/inverted repeats
Capsid	Icosahedral, 162 capsomeres	Assembled in the nucleus; ~100-110 nm diameter
Tegument	Amorphous protein layer	Contains viral proteins including transactivators (e.g. VP16 in HSV), kinases, and immune evasion factors
Envelope	Lipid bilayer with glycoproteins	Acquired by budding through nuclear/Golgi membranes; carries gB, gC, gD, gH/gL (HSV); essential for cell entry

Classification: Three Subfamilies

Subfamily	Human Herpesvirus (HHV)	Common Name	Primary Target Cell	Site of Latency	Spread
Alphaherpesvirinae	HHV-1	Herpes Simplex Virus type 1 (HSV-1)	Mucoepithelial cells	Sensory neurons (trigeminal ganglia)	Close contact (oral)
Alphaherpesvirinae	HHV-2	Herpes Simplex Virus type 2 (HSV-2)	Mucoepithelial cells	Sensory neurons (sacral ganglia)	Close contact (STI)
Alphaherpesvirinae	HHV-3	Varicella-Zoster Virus (VZV)	Mucoepithelial cells, T cells	Sensory neurons (dorsal root ganglia)	Respiratory + close contact
Betaherpesvirinae	HHV-5	Cytomegalovirus (CMV)	Monocytes, macrophages, epithelial cells	Hematopoietic stem cells, monocytes	Saliva, urine, blood, semen, transplant
Betaherpesvirinae	HHV-6 (A & B)	Human Herpesvirus 6	T cells (CD4+)	Monocytes, macrophages	Saliva
Betaherpesvirinae	HHV-7	Human Herpesvirus 7	T cells (CD4+)	T cells	Saliva
Gammaherpesvirinae	HHV-4	Epstein-Barr Virus (EBV)	B cells, epithelial cells	Memory B cells	Saliva ("kissing disease")
Gammaherpesvirinae	HHV-8	Kaposi Sarcoma Herpesvirus (KSHV)	B cells, endothelial cells	B cells	Saliva, sexual contact

Mnemonic for subfamilies: Alpha = fast-replicating, neurotropic; Beta = slow-replicating, large genome; Gamma = lymphotropic, oncogenic

Unique Features Common to ALL Herpesviruses

Large, enveloped icosahedral capsids with dsDNA genomes
Encode many enzymes that manipulate the host cell and immune response
Encode viral DNA polymerase - a key antiviral drug target
DNA replication and capsid assembly occur in the nucleus
Released by exocytosis, cell lysis, and cell-to-cell bridges
Can cause lytic, persistent, latent, and (for EBV) immortalizing infections
Ubiquitous in humans
Cell-mediated immunity is required for control - humoral immunity is insufficient alone

Herpesvirus Replication Cycle

Step-by-step (prototype: HSV)

Attachment - Viral glycoproteins (gB, gC) bind heparan sulfate proteoglycans on host cell surface
Entry - gD binds specific receptor (nectin-1/HVEM); gB + gH/gL mediate envelope-plasma membrane fusion; nucleocapsid released into cytoplasm
Nuclear delivery - Capsid docks at nuclear pore; genome injected into nucleus; circularizes
Gene expression (3 coordinated waves):
- Immediate Early (α/IE) proteins - transcription regulators; "take over the cell"; e.g. ICP0, ICP4 in HSV
- Early (β) proteins - enzymes for DNA replication; thymidine kinase, DNA polymerase, ribonucleotide reductase
- Late (γ) proteins - structural proteins (capsid, glycoproteins); produced after genome replication
DNA replication - Viral DNA polymerase replicates genome in nucleus (rolling circle mechanism)
Capsid assembly - Empty procapsids form in nucleus; filled with DNA
Envelopment - Primary envelopment by budding into perinuclear space (inner nuclear membrane); secondary envelopment at Golgi
Egress - Exocytosis or cell lysis; cell-to-cell spread via tight junctions

Latency Mechanism

Alphaherpesviruses (HSV-1, HSV-2, VZV): Travel retrogradely via axons to sensory nerve ganglia. In neurons, the genome circularizes and persists episomally. Only Latency-Associated Transcripts (LATs) are produced - these encode micro-RNAs that suppress IE gene expression, maintaining latency
Reactivation triggers: fever, UV radiation, stress, immunosuppression, trauma, menstruation
EBV: Persists in memory B cells; reactivates when B cell is activated (especially in tonsils/oropharynx)
CMV: Latent in hematopoietic stem cells and monocytes; reactivates with immunosuppression

Individual Virus Detail

HHV-1: Herpes Simplex Virus Type 1 (HSV-1)

Feature	Detail
Genome	~152 kb linear dsDNA; encodes ~80 proteins
Receptor	Nectin-1 (HVEM-C); heparan sulfate (initial)
Cell tropism	Mucoepithelial cells (lytic), neurons (latent)
Latency site	Trigeminal ganglia
Transmission	Oral contact, respiratory droplets, direct contact
Primary disease	Gingivostomatitis, herpes labialis ("cold sores")
Recurrent disease	Herpes labialis, keratitis
Serious disease	HSV encephalitis (temporal lobe; most common sporadic encephalitis), herpetic whitlow, eczema herpeticum
Neonatal herpes	Acquired at birth; can cause disseminated disease, encephalitis, SEM disease
Key lab finding	Tzanck smear: multinucleated giant cells, Cowdry type A intranuclear inclusions
Treatment	Acyclovir, valacyclovir, famciclovir, penciclovir

HHV-2: Herpes Simplex Virus Type 2 (HSV-2)

Feature	Detail
Genome	~155 kb linear dsDNA; ~68% DNA homology with HSV-1
Latency site	Sacral dorsal root ganglia (S2-S4)
Transmission	Sexual contact; vertical (mother to neonate)
Primary disease	Genital ulcers, vulvovaginitis, urethritis
Recurrent disease	Recurrent genital herpes (more frequent than HSV-1 recurrences genitally)
Serious disease	Neonatal herpes, aseptic meningitis (Mollaret's), sacral radiculopathy
Serology	Type-specific gG-based assay: gG-2 antibody confirms HSV-2
Epidemiology	~20% of US adults seropositive; most unaware
Treatment	Same as HSV-1; suppressive therapy reduces transmission by ~50%

HSV Antiviral Mechanism (shared by HSV-1 and HSV-2):

Acyclovir (ACV) is phosphorylated first by viral thymidine kinase (TK), then by cellular kinases
Acyclovir-triphosphate acts as a chain terminator of viral DNA polymerase (lacks 3'-OH)
Selectivity: viral TK has 200x more affinity for ACV than cellular TK
Resistance: mutations in TK gene (most common) or DNA polymerase gene

HHV-3: Varicella-Zoster Virus (VZV)

Feature	Detail
Genome	~125 kb dsDNA
Primary infection	Varicella (chickenpox) - one of five classic childhood exanthems
Latency site	Dorsal root ganglia and cranial nerve ganglia
Reactivation disease	Herpes zoster (shingles) - dermatomal vesicular rash with severe pain
Incubation	~14 days (range 10-21 days)
Rash characteristics	"Dewdrop on a rose petal" vesicle on erythematous base; all stages present simultaneously; centripetal distribution (trunk > extremities); present on scalp
Complications	Pneumonia (20-30% of adults), encephalitis, cerebellar ataxia, Ramsay Hunt syndrome (geniculate ganglion reactivation), post-herpetic neuralgia
Transmission	Respiratory route (primary VZV); direct contact with zoster lesions can cause varicella in seronegative contacts
Lab diagnosis	Tzanck smear (same as HSV), DFA, PCR, VZV serology
Treatment	Acyclovir (higher doses than HSV), famciclovir, valacyclovir
Prevention	Live attenuated Oka strain vaccine (varicella); live or adjuvanted subunit vaccine (Shingrix) for zoster; VZV immune globulin for post-exposure prophylaxis in immunocompromised

HHV-4: Epstein-Barr Virus (EBV)

Feature	Detail
Genome	~172 kb dsDNA (largest of human herpesviruses)
Cell receptor	CD21 (complement receptor CR2) on B cells; HLA-DR as co-receptor
Primary target	B cells and oropharyngeal epithelial cells
Latency site	Memory B cells (persist lifelong)
Transmission	Saliva ("kissing disease"); blood transfusion; transplant
Primary disease	Infectious mononucleosis (IM): fever, pharyngitis, lymphadenopathy, hepatosplenomegaly, atypical lymphocytes
Atypical lymphocytes	CD8+ T cells reacting to EBV-infected B cells (Downey cells); appear with vacuolated, basophilic cytoplasm
Heterophile antibody	IgM that agglutinates sheep/horse/bovine RBCs but NOT guinea pig kidney cells; basis of Monospot test
Key antigens	VCA (Viral Capsid Antigen), EA (Early Antigen), EBNA (EBV Nuclear Antigen), MA (Membrane Antigen)
Serology interpretation	VCA IgM + = acute; VCA IgG + EBNA IgG- = acute/recent; VCA IgG + EBNA IgG+ = past infection
Immune evasion	Produces IL-10 analog (BCRF-1) that inhibits TH1 CD4+ responses and stimulates B-cell growth
Oncogenic diseases	African Burkitt lymphoma (co-factor: malaria), Nasopharyngeal carcinoma (SE Asia), Hodgkin lymphoma (30-50% cases), Post-transplant lymphoproliferative disease (PTLD), Primary CNS lymphoma (in AIDS)
Transformation	EBV immortalizes B cells via EBNA and LMP proteins (Type III latency)
Treatment	No effective antiviral; acyclovir reduces shedding only; steroids for severe disease (airway obstruction); avoid contact sports (splenomegaly risk)
Contraindication	Ampicillin/amoxicillin causes morbilliform rash in >90% of IM patients

HHV-5: Cytomegalovirus (CMV)

Feature	Detail
Genome	~235 kb dsDNA - largest human herpesvirus genome
Cytopathic effect	Cytomegalic cells (25-35 µm) with "owl's eye" basophilic intranuclear inclusion body
Cell tropism	Macrophages, monocytes, epithelial cells, endothelial cells, fibroblasts
Latency site	Hematopoietic stem cells and monocytes
Transmission	Blood, urine, saliva, semen, breast milk, cervical secretions, transplanted organs
Immunocompetent	Usually asymptomatic; mononucleosis-like syndrome (heterophile-negative)
Congenital CMV	Most common congenital viral infection; 1/150 newborns infected; causes SNHL, intellectual disability, microcephaly, petechiae, "blueberry muffin" rash
Immunocompromised	Retinitis (most common in AIDS - "pizza pie" retina), pneumonitis, colitis, esophagitis, encephalitis, hepatitis, adrenalitis
Lab diagnosis	Histology: owl's eye inclusion; Shell vial culture with early antigen IF; PCR (gold standard); pp65 antigenemia assay
Culture	Diploid human fibroblast cells; slow CPE (4-6 weeks); shell vial faster (1-2 days)
Treatment	Ganciclovir (first line), valganciclovir (oral), foscarnet, cidofovir (renal toxicity); no thymidine kinase - activated by UL97 viral kinase
Resistance	UL97 mutations (most common); UL54 (DNA polymerase) mutations
Prevention	Ganciclovir prophylaxis post-transplant; CMV-negative blood products; leukoreduction

HHV-6A and HHV-6B

Feature	Detail
Cell receptor	CD46 (HHV-6A); CD134 (HHV-6B)
Primary target	CD4+ T cells
Latency	Monocytes/macrophages; chromosomally integrated in ~1% of population
HHV-6B disease	Roseola infantum (Exanthem subitum / 6th disease): high fever then rash in infants 6 months - 2 years; febrile seizures
HHV-6A	Less characterized; possibly more neurotropic; associated with MS (controversial)
Immunocompromised	Encephalitis post-transplant
Treatment	Ganciclovir, foscarnet (no approved therapy)

HHV-7

Feature	Detail
Cell receptor	CD4
Disease	Second cause of roseola; pityriasis rosea (possible association)
Latency	T cells, saliva glands
Clinical significance	Mostly subclinical; can reactivate with immunosuppression

HHV-8: Kaposi Sarcoma Herpesvirus (KSHV)

Feature	Detail
Classification	Gammaherpesvirinae (like EBV); oncogenic
Cell tropism	B cells, endothelial cells, spindle cells
Latency	B cells
Transmission	Saliva, sexual contact (especially MSM), transplantation
Diseases	Kaposi sarcoma (vascular tumor; epidemic in AIDS), Primary Effusion Lymphoma (PEL), Multicentric Castleman disease
Oncogenic mechanism	Encodes viral IL-6, viral cyclin D, FLICE inhibitory protein (vFLIP), and viral GPCR promoting angiogenesis and proliferation
Lab diagnosis	PCR for HHV-8 DNA; immunohistochemistry for LANA-1 on biopsy
Treatment	Antiretroviral therapy (for AIDS-KS), chemotherapy, radiotherapy; no specific antiviral

Comparative Summary Table

Property	HSV-1	HSV-2	VZV	EBV	CMV	HHV-6	HHV-7	HHV-8
HHV #	1	2	3	4	5	6	7	8
Subfamily	Alpha	Alpha	Alpha	Gamma	Beta	Beta	Beta	Gamma
Genome size (kb)	152	155	125	172	235	160	145	165
Latency site	Trigeminal ganglion	Sacral ganglion	Dorsal root ganglion	Memory B cells	HSCs/monocytes	Monocytes	T cells	B cells
Key disease	Cold sores, encephalitis	Genital herpes	Chickenpox/Zoster	Mono, lymphoma	Congenital, retinitis	Roseola	Roseola	Kaposi sarcoma
Oncogenic	No	No	No	Yes	No	No	No	Yes
Microscopy	Cowdry A inclusions	Cowdry A inclusions	Cowdry A inclusions	Downey cells	Owl's eye	-	-	-
Key antiviral	Acyclovir	Acyclovir	Acyclovir	None	Ganciclovir	Ganciclovir	-	None
Activation step	Viral TK	Viral TK	Viral TK	Viral protein kinase	Viral UL97 kinase	-	-	-
Vaccine	No	No	Yes (Oka/Shingrix)	No	No	No	No	No

Sources: Murray's Medical Microbiology 9th Edition (Chapter 43, Table 43.1, Box 43.1, Box 43.5, Box 43.11); Tintinalli's Emergency Medicine; Harrison's Principles of Internal Medicine 22e (2025)

This is a shared conversation. Sign in to Orris to start your own chat.